Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Siemens Fonds Invest GmbH

Siemens Fonds Invest GmbH lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 795.2% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 143,818 shares of the medical equipment provider’s stock after acquiring an additional 127,753 shares during the period. Intuitive Surgical accounts for approximately 3.7% of Siemens Fonds Invest GmbH’s portfolio, making the stock its 4th biggest holding. Siemens Fonds Invest GmbH’s holdings in Intuitive Surgical were worth $75,067,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in ISRG. Vanguard Group Inc. raised its holdings in Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock worth $16,813,478,000 after purchasing an additional 360,591 shares in the last quarter. Geode Capital Management LLC raised its holdings in Intuitive Surgical by 3.2% during the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock worth $4,039,200,000 after purchasing an additional 243,802 shares in the last quarter. Fisher Asset Management LLC raised its holdings in Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after purchasing an additional 86,488 shares in the last quarter. Norges Bank bought a new stake in Intuitive Surgical during the fourth quarter worth approximately $2,401,493,000. Finally, Invesco Ltd. raised its holdings in Intuitive Surgical by 7.7% during the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock worth $2,165,184,000 after purchasing an additional 295,025 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages recently commented on ISRG. Jefferies Financial Group boosted their target price on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the company a “buy” rating in a report on Monday, April 14th. JPMorgan Chase & Co. upped their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Bernstein Bank upped their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Finally, UBS Group increased their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $598.95.

Intuitive Surgical Stock Down 1.0%

ISRG stock opened at $560.28 on Friday. The company has a market capitalization of $200.81 billion, a price-to-earnings ratio of 87.41, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12 month low of $393.98 and a 12 month high of $616.00. The firm has a 50 day moving average of $503.82 and a two-hundred day moving average of $536.13.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the previous year, the firm posted $1.50 earnings per share. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 188 shares of the business’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the sale, the chief financial officer now directly owns 7,162 shares in the company, valued at approximately $4,060,424.28. The trade was a 2.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 32,680 shares of company stock worth $16,854,345. 0.70% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.